Search details
1.
A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.
Clin Infect Dis
; 66(3): 339-345, 2018 01 18.
Article
in English
| MEDLINE | ID: mdl-29029053
2.
Control vaccine formulation - Authors' reply.
Lancet
; 397(10279): 1062, 2021 03 20.
Article
in English
| MEDLINE | ID: mdl-33743868
3.
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience.
Clin Infect Dis
; 63(4): 519-27, 2016 08 15.
Article
in English
| MEDLINE | ID: mdl-27230391
4.
Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
JAMA
; 316(22): 2411-2421, 2016 12 13.
Article
in English
| MEDLINE | ID: mdl-27893068
5.
Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer.
Vaccine
; 41(42): 6194-6205, 2023 10 06.
Article
in English
| MEDLINE | ID: mdl-37704498
6.
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review.
Expert Rev Vaccines
; 21(12): 1799-1817, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36178094
7.
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection.
Int J Cancer
; 129(11): 2632-42, 2011 Dec 01.
Article
in English
| MEDLINE | ID: mdl-21491420
8.
Use of real-world data for HPV vaccine trial follow-up in the Nordic region.
Contemp Clin Trials
; 92: 105996, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32247041
9.
Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up.
Vaccine
; 37(27): 3617-3624, 2019 06 12.
Article
in English
| MEDLINE | ID: mdl-30122646
10.
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90â¯months of follow-up.
Vaccine
; 37(6): 889-897, 2019 02 04.
Article
in English
| MEDLINE | ID: mdl-30638797
11.
Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.
Obstet Gynecol
; 132(2): 261-270, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29995724
12.
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.
Vaccine
; 35(13): 1712-1720, 2017 03 23.
Article
in English
| MEDLINE | ID: mdl-28238631
13.
Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
J Infect
; 50(3): 196-205, 2005 Apr.
Article
in English
| MEDLINE | ID: mdl-15780413
14.
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.
Pediatr Infect Dis J
; 34(9): 983-91, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-26107345
15.
Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black women.
J Adolesc Health
; 52(3): 322-9, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23299013
16.
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, double-blind, placebo-controlled trial in Chinese males and females.
Vaccine
; 30(28): 4284-91, 2012 Jun 13.
Article
in English
| MEDLINE | ID: mdl-22433961
17.
Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural Rwanda.
Am J Trop Med Hyg
; 85(2): 202-6, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21813835
18.
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
Vaccine
; 25(26): 4931-9, 2007 Jun 21.
Article
in English
| MEDLINE | ID: mdl-17499406
19.
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18.
Vaccine
; 24(27-28): 5571-83, 2006 Jul 07.
Article
in English
| MEDLINE | ID: mdl-16753240
20.
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.
Lancet Oncol
; 6(5): 271-8, 2005 May.
Article
in English
| MEDLINE | ID: mdl-15863374